The C4 β-chain: evidence for a genetically determined polymorphismMAUFF, G; STEUER, M; WECK, M et al.Human genetics. 1983, Vol 64, Num 2, pp 186-188, issn 0340-6717Article

SEQUENCE DETERMINATION OF THE THIOLESTER SITE OF THE FOURTH COMPONENT OF HUMAN COMPLEMENTHARRISON RA; THOMAS ML; TACK BF et al.1981; PROC. NATL. ACAD. SCI. U.S.A., BIOL. SCI.; ISSN 0273-1134; USA; DA. 1981; VOL. 78; NO 12; PP. 7388-7392; BIBL. 48 REF.Article

Piezoelectric immunoassay for complement C4 based on a Nafion-modified interface for antibody immobilizationTING DENG; LI, Ji-Shan; HUA WANG et al.Journal of immunological methods. 2005, Vol 299, Num 1-2, pp 1-8, issn 0022-1759, 8 p.Article

A MOLECULAR BASIS FOR THE TWO LOCUS MODEL OF HUMAN COMPLEMENT COMPONENT C4ROOS MH; MOLLENHAUER E; DEMANT P et al.1982; NATURE (LONDON); ISSN 0028-0836; GBR; DA. 1982; VOL. 298; NO 5877; PP. 854-857; BIBL. 29 REF.Article

Revised nomenclature for human complement component C4 : WHO-IUIS nomenclature sbu-committeeJournal of immunological methods. 1993, Vol 163, Num 1, pp 3-7, issn 0022-1759Article

Human C4 haplotypes with duplicated C4A or C4BRAUM, D; AWDEH, Z; ANDERSON, J et al.American journal of human genetics. 1984, Vol 36, Num 1, pp 72-79, issn 0002-9297Article

Classical complement activation induced by pregnancy : implications for management of connective tissue diseasesHOPKINSON, N. D; POWELL, R. J.Journal of clinical pathology. 1992, Vol 45, Num 1, pp 66-67, issn 0021-9746Article

Revised nomenclature for human complement component C4Bulletin of the World Health Organization. 1992, Vol 70, Num 4, pp 531-535, issn 0042-9686Article

AN IMPROVED METHOD FOR SEPARATION OF THE FOURTH COMPONENT OF COMPLEMENT AND C4 INACTIVATING SUBSTANCE = UNE METHODE AMELIOREE POUR LA SEPARATION DU 4EME COMPOSANT DU COMPLEMENT ET DE LA SUBSTANCE INACTIVANT C4SHIMADA K; MAYUMI M; SEKINE T et al.1972; JAP. J. EXPER. MED.; JAP.; DA. 1972; VOL. 42; NO 5; PP. 423-434; BIBL. 15 REF.Serial Issue

Adverse transfusion reactions associated with a precipitating anti-C4 antibody of anti-Rodgers specificityLAMBIN, P; LE PENNEC, P. Y; HAUPTMANN, G et al.Vox sanguinis (Basel. 1956). 1984, Vol 47, Num 3, pp 242-249, issn 0042-9007Article

Functional studies on the secreted form of human C4 (C4^s), two incompletely processed two-subunit C4 molecules (β-α+γ and β+α-γ), and pro-C4CHAN, A. C; ATKINSON, J. P.The Journal of immunology (1950). 1984, Vol 132, Num 4, pp 1967-1971, issn 0022-1767Article

The complement component C4 in black Americans with Type 1 (insulin-dependent) diabetes mellitusBUDOWLE, B; ROSEMAN, J. M; GO, R. C. P et al.Diabetologia (Berlin). 1984, Vol 26, Num 2, pp 166-168, issn 0012-186XArticle

The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4ISENMAN, D. E; YOUNG, J. R.The Journal of immunology (1950). 1984, Vol 132, Num 6, pp 3019-3027, issn 0022-1767Article

Effect of radiographic contrast media on complement components C3 and C4: generation of C3b-like C3 and C4b- like C4VON ZABERN, I; PRZYKLENK, H; VOGT, W et al.International journal of immunopharmacology. 1983, Vol 5, Num 6, pp 503-513, issn 0192-0561Article

Post-translational modification of the fourth component of complement: effect of tunicamycin and amino acid analogs on the formation of the internal thiol ester and disulfide bondsKARP, D. R.The Journal of biological chemistry (Print). 1983, Vol 258, Num 23, pp 14490-14495, issn 0021-9258Article

HUMAN C4-BINDING PROTEIN. I. ISOLATION AND CHARACTERIZATION.SCHARFSTEIN J; FERREIRA A; GIGLI I et al.1978; J. EXPER. MED.; USA; DA. 1978; VOL. 148; NO 1; PP. 207-222; BIBL. 24 REF.Article

COMPLEMENT ACTIVATION IN MIGRAINE.LORD GDA; DUCKWORTH JW; CHARLESWORTH JA et al.1977; LANCET; G.B.; DA. 1977; NO 8015; PP. 781-782; BIBL. 13 REF.Article

THE GENETIC POLYMORPHISM OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT: METHODOLOGICAL ASPECTS AND A PRESENTATION OF LINKAGE AND ASSOCIATION DATA RELEVANT TO ITS LOCALIZATION IN THE HLA REGION.OLAISEN TB; JONASSEN R; GEDDE DAHL J JR et al.1977; J. EXP. MED.; U.S.A.; DA. 1977; VOL. 146; NO 5; PP. 1380-1389; BIBL. 1 P. 1/2Article

Screening for polymorphism in the tyrosine-sulfated region of human C4MEJIA, J. E; KHALID LAHSAINI; TONGIO, M.-M et al.Human molecular genetics (Print). 1993, Vol 2, Num 10, pp 1733-1734, issn 0964-6906Article

Binding of human C4 to C-reactive protein-pneumococcal C-polysaccharide complexes during activation of the classical complement pathwayVOLANAKIS, J. E; NARKATES, A. J.Molecular immunology. 1983, Vol 20, Num 11, pp 1201-1207, issn 0161-5890Article

Post-translational modification of the fourth component of complement: sulfation of the α-chainKARP, D. R.The Journal of biological chemistry (Print). 1983, Vol 258, Num 21, pp 12745-12748, issn 0021-9258Article

PRECURSOR COMPLEMENT PROTEIN (PRO-C4) IS CONVERTED IN VITRO TO NATIVE C4 BY PLASMINGOLDBERGER G; COLTEN HR.1980; NATURE; GBR; DA. 1980; VOL. 286; NO 5772; PP. 514-516; BIBL. 15 REF.Article

Antigenic determinants of human C4, Rodgers and ChidoGILES, C. M.Experimental and clinical immunogenetics. 1988, Vol 5, Num 2-3, pp 99-114, issn 0254-9670Article

Oligosaccharide structure of human C4CHAN, A. C; ATKINSON, J. P.The Journal of immunology (1950). 1985, Vol 134, Num 3, pp 1790-1798, issn 0022-1767Article

The β-cys-γ-Glu thiolester bond in human C3, C4, and α₂-macroglobulinTACK, B. F.Springer seminars in immunopathology. 1983, Vol 6, Num 4, pp 259-282, issn 0344-4325Article